1. Home
  2. EDSA vs ULY Comparison

EDSA vs ULY Comparison

Compare EDSA & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • ULY
  • Stock Information
  • Founded
  • EDSA 2015
  • ULY 2013
  • Country
  • EDSA Canada
  • ULY United States
  • Employees
  • EDSA N/A
  • ULY 158
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • EDSA Health Care
  • ULY
  • Exchange
  • EDSA Nasdaq
  • ULY Nasdaq
  • Market Cap
  • EDSA 6.2M
  • ULY 7.4M
  • IPO Year
  • EDSA N/A
  • ULY N/A
  • Fundamental
  • Price
  • EDSA $1.96
  • ULY $5.48
  • Analyst Decision
  • EDSA Strong Buy
  • ULY Strong Buy
  • Analyst Count
  • EDSA 1
  • ULY 1
  • Target Price
  • EDSA $21.00
  • ULY $12.00
  • AVG Volume (30 Days)
  • EDSA 34.1K
  • ULY 40.3K
  • Earning Date
  • EDSA 05-14-2025
  • ULY 05-13-2025
  • Dividend Yield
  • EDSA N/A
  • ULY N/A
  • EPS Growth
  • EDSA N/A
  • ULY N/A
  • EPS
  • EDSA N/A
  • ULY N/A
  • Revenue
  • EDSA N/A
  • ULY $134,085,000.00
  • Revenue This Year
  • EDSA N/A
  • ULY N/A
  • Revenue Next Year
  • EDSA N/A
  • ULY $17.87
  • P/E Ratio
  • EDSA N/A
  • ULY N/A
  • Revenue Growth
  • EDSA N/A
  • ULY N/A
  • 52 Week Low
  • EDSA $1.55
  • ULY $2.99
  • 52 Week High
  • EDSA $5.59
  • ULY $24.48
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.93
  • ULY 38.70
  • Support Level
  • EDSA $1.96
  • ULY $5.29
  • Resistance Level
  • EDSA $2.06
  • ULY $7.83
  • Average True Range (ATR)
  • EDSA 0.10
  • ULY 0.80
  • MACD
  • EDSA -0.00
  • ULY -0.47
  • Stochastic Oscillator
  • EDSA 30.77
  • ULY 3.82

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: